These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 12868117)

  • 1. Cisplatin nephrotoxicity affects magnesium and calcium metabolism.
    Goren MP
    Med Pediatr Oncol; 2003 Sep; 41(3):186-9. PubMed ID: 12868117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amifostine protects against cisplatin-induced nephrotoxicity in a child with medulloblastoma.
    Hayek M; Srinivasan A
    Pediatr Hematol Oncol; 2003; 20(3):253-6. PubMed ID: 12637222
    [No Abstract]   [Full Text] [Related]  

  • 3. Amifostine reduces the incidence of cumulative nephrotoxicity from cisplatin: laboratory and clinical aspects.
    Capizzi RL
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):72-81. PubMed ID: 10348264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity.
    Chirino YI; Pedraza-Chaverri J
    Exp Toxicol Pathol; 2009 May; 61(3):223-42. PubMed ID: 18986801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of the cytoprotectant amifostine.
    Lindemann K
    Clin J Oncol Nurs; 1998 Jul; 2(3):101-4. PubMed ID: 10232150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amifostine.
    Viele C
    Clin J Oncol Nurs; 1999 Jul; 3(3):128, 131. PubMed ID: 10690046
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of ellagic acid against cisplatin-induced nephrotoxicity and oxidative stress in rats.
    Ateşşahín A; Ceríbaşi AO; Yuce A; Bulmus O; Cikim G
    Basic Clin Pharmacol Toxicol; 2007 Feb; 100(2):121-6. PubMed ID: 17244261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal magnesium wasting associated with therapeutic agents.
    Shah GM; Kirschenbaum MA
    Miner Electrolyte Metab; 1991; 17(1):58-64. PubMed ID: 1722865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin nephrotoxicity.
    Meyer KB; Madias NE
    Miner Electrolyte Metab; 1994; 20(4):201-13. PubMed ID: 7845323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of L-arginine against cisplatin-induced renal oxidative stress and toxicity: role of nitric oxide.
    Saleh S; El-Demerdash E
    Basic Clin Pharmacol Toxicol; 2005 Aug; 97(2):91-7. PubMed ID: 15998355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amifostine in reducing cisplatin toxicity.
    Markman M
    Semin Oncol; 1998 Oct; 25(5):522-4. PubMed ID: 9783591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats.
    Atessahin A; Yilmaz S; Karahan I; Ceribasi AO; Karaoglu A
    Toxicology; 2005 Sep; 212(2-3):116-23. PubMed ID: 15946783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extract of Prunus persica flesh (PPFE) improves chemotherapeutic efficacy and protects against nephrotoxicity in cisplatin-treated mice.
    Lee CK; Park KK; Hwang JK; Lee SK; Chung WY
    Phytother Res; 2009 Jul; 23(7):999-1005. PubMed ID: 19140122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity prevention with amifostine in pediatric osteosarcoma patients treated with cisplatin and doxorubicin.
    Gallegos-Castorena S; Martínez-Avalos A; Mohar-Betancourt A; Guerrero-Avendaño G; Zapata-Tarrés M; Medina-Sansón A
    Pediatr Hematol Oncol; 2007 Sep; 24(6):403-8. PubMed ID: 17710657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of amifostine in the treatment of head and neck cancer with cisplatin-radiotherapy.
    Marcu LG
    Eur J Cancer Care (Engl); 2009 Mar; 18(2):116-23. PubMed ID: 19267726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of apocynin against cisplatin-induced oxidative stress and nephrotoxicity.
    Chirino YI; Sánchez-González DJ; Martínez-Martínez CM; Cruz C; Pedraza-Chaverri J
    Toxicology; 2008 Mar; 245(1-2):18-23. PubMed ID: 18243469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse effects of cytotoxics-platinum agents.
    Selvaratnam G; Philips RH; Mohamed AK; Radzi A
    Adverse Drug React Toxicol Rev; 1997 Aug; 16(3):171-97. PubMed ID: 9512763
    [No Abstract]   [Full Text] [Related]  

  • 18. Modern methods for diagnosis and monitoring of nephrotoxicity during antitumor therapy with platinum derivatives.
    Lyubimova NV; Topchieva SV; Averinova SG; Kashkadaeva AV; Gorbunova VA; Shiryaev SV; Kushlinskii NE
    Bull Exp Biol Med; 2000 Sep; 130(9):886-91. PubMed ID: 11177273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria.
    Santos NA; Catão CS; Martins NM; Curti C; Bianchi ML; Santos AC
    Arch Toxicol; 2007 Jul; 81(7):495-504. PubMed ID: 17216432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular hydrogen alleviates nephrotoxicity induced by an anti-cancer drug cisplatin without compromising anti-tumor activity in mice.
    Nakashima-Kamimura N; Mori T; Ohsawa I; Asoh S; Ohta S
    Cancer Chemother Pharmacol; 2009 Sep; 64(4):753-61. PubMed ID: 19148645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.